Bengaluru, India · Founded 2018 · Privately Held (backing)
Developer of a cell therapy intended to provide cell and gene therapies for cancer treatment. Immuneel is based in Bengaluru, India and was founded in 2018. Its last known valuation is $67.9 million. It has raised $38 million.
Last price · $/share
—
Implied valuation
$67.9M
Total raised
$38.0M
Last round
—
Cap table — not yet on record
Immuneel's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Immuneel with a free account
·The complete investor list: 16 names
·Watch Immuneel: the Monday email on marks, rounds and moves
